nodes	percent_of_prediction	percent_of_DWPC	metapath
Tenofovir—ABCC10—Etoposide—uterine cancer	0.218	0.351	CbGbCtD
Tenofovir—ABCC10—Doxorubicin—uterine cancer	0.149	0.239	CbGbCtD
Tenofovir—ABCC2—Carboplatin—uterine cancer	0.0743	0.12	CbGbCtD
Tenofovir—ABCC2—Etoposide—uterine cancer	0.0624	0.1	CbGbCtD
Tenofovir—CYP1A2—Progesterone—uterine cancer	0.052	0.0836	CbGbCtD
Tenofovir—ABCC2—Doxorubicin—uterine cancer	0.0425	0.0684	CbGbCtD
Tenofovir—CYP1A2—Etoposide—uterine cancer	0.0233	0.0374	CbGbCtD
Tenofovir—AK2—Synthesis and interconversion of nucleotide di- and triphosphates—RRM2—uterine cancer	0.00986	0.102	CbGpPWpGaD
Tenofovir—NME2—Nucleotide Metabolism—POLD1—uterine cancer	0.00785	0.0814	CbGpPWpGaD
Tenofovir—NME2—Synthesis and interconversion of nucleotide di- and triphosphates—RRM2—uterine cancer	0.00683	0.0709	CbGpPWpGaD
Tenofovir—NME2—Nucleotide Metabolism—RRM2—uterine cancer	0.00654	0.0679	CbGpPWpGaD
Tenofovir—AK2—myometrium—uterine cancer	0.00625	0.0531	CbGeAlD
Tenofovir—NME1—Synthesis and interconversion of nucleotide di- and triphosphates—RRM2—uterine cancer	0.00518	0.0537	CbGpPWpGaD
Tenofovir—NME1-NME2—female reproductive system—uterine cancer	0.0048	0.0409	CbGeAlD
Tenofovir—ABCC10—ABC-family proteins mediated transport—ABCC9—uterine cancer	0.00467	0.0485	CbGpPWpGaD
Tenofovir—AK4—myometrium—uterine cancer	0.00462	0.0393	CbGeAlD
Tenofovir—AK2—mammalian vulva—uterine cancer	0.00425	0.0362	CbGeAlD
Tenofovir—AK2—uterus—uterine cancer	0.00405	0.0344	CbGeAlD
Tenofovir—AK4—uterine cervix—uterine cancer	0.0036	0.0306	CbGeAlD
Tenofovir—NME2—epithelium—uterine cancer	0.00354	0.0301	CbGeAlD
Tenofovir—Adenosine triphosphate—ABCC9—uterine cancer	0.00352	0.669	CrCbGaD
Tenofovir—NME1—renal system—uterine cancer	0.00349	0.0297	CbGeAlD
Tenofovir—AK4—decidua—uterine cancer	0.00343	0.0291	CbGeAlD
Tenofovir—AK4—renal system—uterine cancer	0.00336	0.0286	CbGeAlD
Tenofovir—AK2—female gonad—uterine cancer	0.00331	0.0282	CbGeAlD
Tenofovir—AK2—vagina—uterine cancer	0.00329	0.028	CbGeAlD
Tenofovir—NME2—renal system—uterine cancer	0.00329	0.028	CbGeAlD
Tenofovir—AK4—endometrium—uterine cancer	0.00325	0.0276	CbGeAlD
Tenofovir—AK4—mammalian vulva—uterine cancer	0.00315	0.0267	CbGeAlD
Tenofovir—NME1—uterus—uterine cancer	0.00311	0.0264	CbGeAlD
Tenofovir—AK2—Nucleotide metabolism—RRM2—uterine cancer	0.00305	0.0316	CbGpPWpGaD
Tenofovir—AK4—uterus—uterine cancer	0.003	0.0255	CbGeAlD
Tenofovir—NME1-NME2—lymph node—uterine cancer	0.00281	0.0239	CbGeAlD
Tenofovir—NME1—female reproductive system—uterine cancer	0.00279	0.0238	CbGeAlD
Tenofovir—AK4—female reproductive system—uterine cancer	0.00269	0.0229	CbGeAlD
Tenofovir—NME2—female reproductive system—uterine cancer	0.00263	0.0224	CbGeAlD
Tenofovir—NME1—female gonad—uterine cancer	0.00254	0.0216	CbGeAlD
Tenofovir—AK4—female gonad—uterine cancer	0.00245	0.0208	CbGeAlD
Tenofovir—AK4—vagina—uterine cancer	0.00244	0.0207	CbGeAlD
Tenofovir—NME2—female gonad—uterine cancer	0.0024	0.0204	CbGeAlD
Tenofovir—ABCC10—myometrium—uterine cancer	0.00219	0.0186	CbGeAlD
Tenofovir—NME1—Levonorgestrel—Progesterone—uterine cancer	0.00215	1	CbGdCrCtD
Tenofovir—AK2—lymph node—uterine cancer	0.00213	0.0181	CbGeAlD
Tenofovir—NME2—Nucleotide metabolism—RRM2—uterine cancer	0.00211	0.0219	CbGpPWpGaD
Tenofovir—NME2—Validated targets of C-MYC transcriptional activation—HMGA1—uterine cancer	0.00176	0.0183	CbGpPWpGaD
Tenofovir—Adenosine triphosphate—AKT1—uterine cancer	0.00175	0.331	CrCbGaD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—MAP3K4—uterine cancer	0.00175	0.0181	CbGpPWpGaD
Tenofovir—ABCC10—uterine cervix—uterine cancer	0.00171	0.0145	CbGeAlD
Tenofovir—ABCC4—ABC-family proteins mediated transport—ABCC9—uterine cancer	0.0017	0.0176	CbGpPWpGaD
Tenofovir—NME1—lymph node—uterine cancer	0.00164	0.0139	CbGeAlD
Tenofovir—ABCC10—decidua—uterine cancer	0.00162	0.0138	CbGeAlD
Tenofovir—NME1—Nucleotide metabolism—RRM2—uterine cancer	0.0016	0.0166	CbGpPWpGaD
Tenofovir—ABCC10—renal system—uterine cancer	0.0016	0.0136	CbGeAlD
Tenofovir—AK4—lymph node—uterine cancer	0.00158	0.0134	CbGeAlD
Tenofovir—ABCC10—endometrium—uterine cancer	0.00154	0.0131	CbGeAlD
Tenofovir—NME2—lymph node—uterine cancer	0.00154	0.0131	CbGeAlD
Tenofovir—ABCC10—mammalian vulva—uterine cancer	0.00149	0.0127	CbGeAlD
Tenofovir—ABCC2—ABC-family proteins mediated transport—ABCC9—uterine cancer	0.00144	0.0149	CbGpPWpGaD
Tenofovir—ABCC10—uterus—uterine cancer	0.00142	0.0121	CbGeAlD
Tenofovir—NME1—Posttranslational regulation of adherens junction stability and dissassembly—IGF1R—uterine cancer	0.00138	0.0144	CbGpPWpGaD
Tenofovir—NME1—Validated targets of C-MYC transcriptional activation—HMGA1—uterine cancer	0.00134	0.0138	CbGpPWpGaD
Tenofovir—ABCC4—renal system—uterine cancer	0.00132	0.0113	CbGeAlD
Tenofovir—SLC22A8—renal system—uterine cancer	0.00131	0.0112	CbGeAlD
Tenofovir—ABCC2—renal system—uterine cancer	0.00128	0.0109	CbGeAlD
Tenofovir—ABCC10—female reproductive system—uterine cancer	0.00128	0.0109	CbGeAlD
Tenofovir—ABCC4—Fluoropyrimidine Activity—RRM2—uterine cancer	0.00119	0.0124	CbGpPWpGaD
Tenofovir—ABCC4—uterus—uterine cancer	0.00118	0.01	CbGeAlD
Tenofovir—NME1—E-cadherin signaling in the nascent adherens junction—CDH1—uterine cancer	0.00116	0.0121	CbGpPWpGaD
Tenofovir—ABCC10—female gonad—uterine cancer	0.00116	0.00989	CbGeAlD
Tenofovir—ABCC10—vagina—uterine cancer	0.00116	0.00983	CbGeAlD
Tenofovir—NME2—Validated targets of C-MYC transcriptional activation—SMAD3—uterine cancer	0.00115	0.012	CbGpPWpGaD
Tenofovir—NME2—Validated targets of C-MYC transcriptional activation—BIRC5—uterine cancer	0.00109	0.0113	CbGpPWpGaD
Tenofovir—NME1—Posttranslational regulation of adherens junction stability and dissassembly—MET—uterine cancer	0.00107	0.0111	CbGpPWpGaD
Tenofovir—ABCC4—female reproductive system—uterine cancer	0.00106	0.00901	CbGeAlD
Tenofovir—ABCC2—female reproductive system—uterine cancer	0.00103	0.00872	CbGeAlD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—INHBA—uterine cancer	0.000975	0.0101	CbGpPWpGaD
Tenofovir—ABCC4—female gonad—uterine cancer	0.000964	0.0082	CbGeAlD
Tenofovir—NME1—Arf6 trafficking events—CDH1—uterine cancer	0.00094	0.00974	CbGpPWpGaD
Tenofovir—NME1—Posttranslational regulation of adherens junction stability and dissassembly—CDH1—uterine cancer	0.000924	0.00958	CbGpPWpGaD
Tenofovir—CYP1A2—renal system—uterine cancer	0.000899	0.00765	CbGeAlD
Tenofovir—NME1—Validated targets of C-MYC transcriptional activation—SMAD3—uterine cancer	0.000874	0.00906	CbGpPWpGaD
Tenofovir—NME1—E-cadherin signaling in the nascent adherens junction—CTNNB1—uterine cancer	0.000858	0.0089	CbGpPWpGaD
Tenofovir—Urethral disorder—Medroxyprogesterone Acetate—uterine cancer	0.000853	0.00544	CcSEcCtD
Tenofovir—Mental disorder—Progesterone—uterine cancer	0.000841	0.00536	CcSEcCtD
Tenofovir—Malnutrition—Progesterone—uterine cancer	0.000836	0.00533	CcSEcCtD
Tenofovir—NME1—Validated targets of C-MYC transcriptional activation—BIRC5—uterine cancer	0.000826	0.00856	CbGpPWpGaD
Tenofovir—Serum creatinine increased—Doxorubicin—uterine cancer	0.000825	0.00526	CcSEcCtD
Tenofovir—Flatulence—Progesterone—uterine cancer	0.000824	0.00525	CcSEcCtD
Tenofovir—Back pain—Progesterone—uterine cancer	0.000809	0.00515	CcSEcCtD
Tenofovir—Immune system disorder—Medroxyprogesterone Acetate—uterine cancer	0.000786	0.00501	CcSEcCtD
Tenofovir—Mediastinal disorder—Medroxyprogesterone Acetate—uterine cancer	0.000784	0.005	CcSEcCtD
Tenofovir—Hepatomegaly—Epirubicin—uterine cancer	0.000775	0.00494	CcSEcCtD
Tenofovir—Angioedema—Progesterone—uterine cancer	0.000764	0.00487	CcSEcCtD
Tenofovir—Mental disorder—Medroxyprogesterone Acetate—uterine cancer	0.000762	0.00486	CcSEcCtD
Tenofovir—Pneumonia—Dactinomycin—uterine cancer	0.000761	0.00485	CcSEcCtD
Tenofovir—Malnutrition—Medroxyprogesterone Acetate—uterine cancer	0.000758	0.00483	CcSEcCtD
Tenofovir—ABCC10—lymph node—uterine cancer	0.000748	0.00636	CbGeAlD
Tenofovir—Flatulence—Medroxyprogesterone Acetate—uterine cancer	0.000747	0.00476	CcSEcCtD
Tenofovir—Back pain—Medroxyprogesterone Acetate—uterine cancer	0.000733	0.00467	CcSEcCtD
Tenofovir—Hepatomegaly—Doxorubicin—uterine cancer	0.000717	0.00457	CcSEcCtD
Tenofovir—Myalgia—Progesterone—uterine cancer	0.000712	0.00454	CcSEcCtD
Tenofovir—Arthralgia—Progesterone—uterine cancer	0.000712	0.00454	CcSEcCtD
Tenofovir—Chest pain—Progesterone—uterine cancer	0.000712	0.00454	CcSEcCtD
Tenofovir—Anxiety—Progesterone—uterine cancer	0.000709	0.00452	CcSEcCtD
Tenofovir—Unspecified disorder of skin and subcutaneous tissue—Progesterone—uterine cancer	0.000707	0.00451	CcSEcCtD
Tenofovir—NME1—Arf6 trafficking events—CTNNB1—uterine cancer	0.000694	0.00719	CbGpPWpGaD
Tenofovir—Angioedema—Medroxyprogesterone Acetate—uterine cancer	0.000692	0.00441	CcSEcCtD
Tenofovir—NME1—Posttranslational regulation of adherens junction stability and dissassembly—CTNNB1—uterine cancer	0.000682	0.00707	CbGpPWpGaD
Tenofovir—Hepatitis—Dactinomycin—uterine cancer	0.000679	0.00433	CcSEcCtD
Tenofovir—Glycosuria—Epirubicin—uterine cancer	0.000677	0.00431	CcSEcCtD
Tenofovir—Nervous system disorder—Progesterone—uterine cancer	0.000669	0.00427	CcSEcCtD
Tenofovir—Skin disorder—Progesterone—uterine cancer	0.000663	0.00422	CcSEcCtD
Tenofovir—Hyperhidrosis—Progesterone—uterine cancer	0.00066	0.0042	CcSEcCtD
Tenofovir—Anorexia—Progesterone—uterine cancer	0.00065	0.00415	CcSEcCtD
Tenofovir—Arthralgia—Medroxyprogesterone Acetate—uterine cancer	0.000645	0.00411	CcSEcCtD
Tenofovir—Chest pain—Medroxyprogesterone Acetate—uterine cancer	0.000645	0.00411	CcSEcCtD
Tenofovir—Myalgia—Medroxyprogesterone Acetate—uterine cancer	0.000645	0.00411	CcSEcCtD
Tenofovir—Anxiety—Medroxyprogesterone Acetate—uterine cancer	0.000643	0.0041	CcSEcCtD
Tenofovir—Unspecified disorder of skin and subcutaneous tissue—Medroxyprogesterone Acetate—uterine cancer	0.000641	0.00408	CcSEcCtD
Tenofovir—Glycosuria—Doxorubicin—uterine cancer	0.000626	0.00399	CcSEcCtD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—EZH2—uterine cancer	0.000626	0.00649	CbGpPWpGaD
Tenofovir—Musculoskeletal discomfort—Progesterone—uterine cancer	0.000622	0.00396	CcSEcCtD
Tenofovir—ABCC4—lymph node—uterine cancer	0.00062	0.00527	CbGeAlD
Tenofovir—Insomnia—Progesterone—uterine cancer	0.000617	0.00393	CcSEcCtD
Tenofovir—Dyspnoea—Progesterone—uterine cancer	0.000608	0.00388	CcSEcCtD
Tenofovir—Nervous system disorder—Medroxyprogesterone Acetate—uterine cancer	0.000606	0.00386	CcSEcCtD
Tenofovir—ABCC4—Fluoropyrimidine Activity—MTHFR—uterine cancer	0.000604	0.00626	CbGpPWpGaD
Tenofovir—Dyspepsia—Progesterone—uterine cancer	0.000601	0.00383	CcSEcCtD
Tenofovir—Skin disorder—Medroxyprogesterone Acetate—uterine cancer	0.000601	0.00383	CcSEcCtD
Tenofovir—ABCC2—lymph node—uterine cancer	0.0006	0.0051	CbGeAlD
Tenofovir—Hyperhidrosis—Medroxyprogesterone Acetate—uterine cancer	0.000598	0.00381	CcSEcCtD
Tenofovir—Decreased appetite—Progesterone—uterine cancer	0.000593	0.00378	CcSEcCtD
Tenofovir—NME1—E-cadherin signaling in the nascent adherens junction—PIK3CA—uterine cancer	0.00059	0.00612	CbGpPWpGaD
Tenofovir—Anorexia—Medroxyprogesterone Acetate—uterine cancer	0.000589	0.00376	CcSEcCtD
Tenofovir—Gastrointestinal disorder—Progesterone—uterine cancer	0.000589	0.00375	CcSEcCtD
Tenofovir—Fatigue—Progesterone—uterine cancer	0.000588	0.00375	CcSEcCtD
Tenofovir—AK2—Metabolism—NDUFB11—uterine cancer	0.000586	0.00608	CbGpPWpGaD
Tenofovir—AK2—Metabolism—SRD5A2—uterine cancer	0.000586	0.00608	CbGpPWpGaD
Tenofovir—Pain—Progesterone—uterine cancer	0.000584	0.00372	CcSEcCtD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—ESR2—uterine cancer	0.00058	0.00601	CbGpPWpGaD
Tenofovir—Creatinine increased—Epirubicin—uterine cancer	0.000576	0.00367	CcSEcCtD
Tenofovir—Bone pain—Epirubicin—uterine cancer	0.000573	0.00365	CcSEcCtD
Tenofovir—Musculoskeletal discomfort—Medroxyprogesterone Acetate—uterine cancer	0.000563	0.00359	CcSEcCtD
Tenofovir—NME2—Validated targets of C-MYC transcriptional activation—EP300—uterine cancer	0.000561	0.00582	CbGpPWpGaD
Tenofovir—Insomnia—Medroxyprogesterone Acetate—uterine cancer	0.000559	0.00356	CcSEcCtD
Tenofovir—Gastrointestinal pain—Progesterone—uterine cancer	0.000558	0.00356	CcSEcCtD
Tenofovir—Dyspnoea—Medroxyprogesterone Acetate—uterine cancer	0.000551	0.00351	CcSEcCtD
Tenofovir—Pneumonia—Etoposide—uterine cancer	0.00055	0.00351	CcSEcCtD
Tenofovir—Infestation—Etoposide—uterine cancer	0.000547	0.00349	CcSEcCtD
Tenofovir—Infestation NOS—Etoposide—uterine cancer	0.000547	0.00349	CcSEcCtD
Tenofovir—Dyspepsia—Medroxyprogesterone Acetate—uterine cancer	0.000544	0.00347	CcSEcCtD
Tenofovir—Abdominal pain—Progesterone—uterine cancer	0.000539	0.00344	CcSEcCtD
Tenofovir—Body temperature increased—Progesterone—uterine cancer	0.000539	0.00344	CcSEcCtD
Tenofovir—Renal failure—Etoposide—uterine cancer	0.000538	0.00343	CcSEcCtD
Tenofovir—Decreased appetite—Medroxyprogesterone Acetate—uterine cancer	0.000538	0.00343	CcSEcCtD
Tenofovir—Neuropathy peripheral—Etoposide—uterine cancer	0.000536	0.00342	CcSEcCtD
Tenofovir—Gastrointestinal disorder—Medroxyprogesterone Acetate—uterine cancer	0.000534	0.0034	CcSEcCtD
Tenofovir—Creatinine increased—Doxorubicin—uterine cancer	0.000533	0.0034	CcSEcCtD
Tenofovir—Fatigue—Medroxyprogesterone Acetate—uterine cancer	0.000533	0.0034	CcSEcCtD
Tenofovir—Bone pain—Doxorubicin—uterine cancer	0.00053	0.00338	CcSEcCtD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—STK11—uterine cancer	0.000527	0.00546	CbGpPWpGaD
Tenofovir—Hepatobiliary disease—Etoposide—uterine cancer	0.000518	0.0033	CcSEcCtD
Tenofovir—Gastrointestinal pain—Medroxyprogesterone Acetate—uterine cancer	0.000506	0.00322	CcSEcCtD
Tenofovir—Myalgia—Dactinomycin—uterine cancer	0.000503	0.00321	CcSEcCtD
Tenofovir—Hypersensitivity—Progesterone—uterine cancer	0.000503	0.0032	CcSEcCtD
Tenofovir—Asthenia—Progesterone—uterine cancer	0.00049	0.00312	CcSEcCtD
Tenofovir—Abdominal pain—Medroxyprogesterone Acetate—uterine cancer	0.000489	0.00312	CcSEcCtD
Tenofovir—Body temperature increased—Medroxyprogesterone Acetate—uterine cancer	0.000489	0.00312	CcSEcCtD
Tenofovir—ABCC10—Transmembrane transport of small molecules—ABCC9—uterine cancer	0.000488	0.00506	CbGpPWpGaD
Tenofovir—Urinary tract disorder—Etoposide—uterine cancer	0.000485	0.00309	CcSEcCtD
Tenofovir—Pruritus—Progesterone—uterine cancer	0.000483	0.00308	CcSEcCtD
Tenofovir—NME1—E-cadherin signaling in the nascent adherens junction—AKT1—uterine cancer	0.000482	0.005	CbGpPWpGaD
Tenofovir—Urethral disorder—Etoposide—uterine cancer	0.000482	0.00307	CcSEcCtD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—CDKN2B—uterine cancer	0.000472	0.0049	CbGpPWpGaD
Tenofovir—Diarrhoea—Progesterone—uterine cancer	0.000467	0.00298	CcSEcCtD
Tenofovir—Anorexia—Dactinomycin—uterine cancer	0.00046	0.00293	CcSEcCtD
Tenofovir—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.000456	0.0029	CcSEcCtD
Tenofovir—Dizziness—Progesterone—uterine cancer	0.000451	0.00288	CcSEcCtD
Tenofovir—Immune system disorder—Etoposide—uterine cancer	0.000444	0.00283	CcSEcCtD
Tenofovir—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.000444	0.00283	CcSEcCtD
Tenofovir—Mediastinal disorder—Etoposide—uterine cancer	0.000443	0.00282	CcSEcCtD
Tenofovir—Musculoskeletal discomfort—Dactinomycin—uterine cancer	0.000439	0.0028	CcSEcCtD
Tenofovir—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.000437	0.00279	CcSEcCtD
Tenofovir—Vomiting—Progesterone—uterine cancer	0.000434	0.00277	CcSEcCtD
Tenofovir—NME1—Posttranslational regulation of adherens junction stability and dissassembly—HRAS—uterine cancer	0.000434	0.0045	CbGpPWpGaD
Tenofovir—Renal failure acute—Epirubicin—uterine cancer	0.000431	0.00275	CcSEcCtD
Tenofovir—Rash—Progesterone—uterine cancer	0.00043	0.00274	CcSEcCtD
Tenofovir—Dermatitis—Progesterone—uterine cancer	0.00043	0.00274	CcSEcCtD
Tenofovir—Headache—Progesterone—uterine cancer	0.000427	0.00272	CcSEcCtD
Tenofovir—NME1—Validated targets of C-MYC transcriptional activation—EP300—uterine cancer	0.000426	0.00441	CbGpPWpGaD
Tenofovir—AK2—Metabolism—AKR1B1—uterine cancer	0.000424	0.00439	CbGpPWpGaD
Tenofovir—AK2—Metabolism—STAR—uterine cancer	0.000424	0.00439	CbGpPWpGaD
Tenofovir—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.000423	0.0027	CcSEcCtD
Tenofovir—Decreased appetite—Dactinomycin—uterine cancer	0.000419	0.00267	CcSEcCtD
Tenofovir—Renal impairment—Epirubicin—uterine cancer	0.000418	0.00267	CcSEcCtD
Tenofovir—Fatigue—Dactinomycin—uterine cancer	0.000416	0.00265	CcSEcCtD
Tenofovir—Back pain—Etoposide—uterine cancer	0.000414	0.00264	CcSEcCtD
Tenofovir—Pain—Dactinomycin—uterine cancer	0.000412	0.00263	CcSEcCtD
Tenofovir—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.000409	0.00261	CcSEcCtD
Tenofovir—NME2—Metabolism—NDUFB11—uterine cancer	0.000406	0.00421	CbGpPWpGaD
Tenofovir—NME2—Metabolism—SRD5A2—uterine cancer	0.000406	0.00421	CbGpPWpGaD
Tenofovir—Nausea—Progesterone—uterine cancer	0.000405	0.00258	CcSEcCtD
Tenofovir—NME2—Validated targets of C-MYC transcriptional activation—TP53—uterine cancer	0.000402	0.00417	CbGpPWpGaD
Tenofovir—Renal failure acute—Doxorubicin—uterine cancer	0.000399	0.00254	CcSEcCtD
Tenofovir—Gastrointestinal pain—Dactinomycin—uterine cancer	0.000394	0.00251	CcSEcCtD
Tenofovir—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.000393	0.00251	CcSEcCtD
Tenofovir—Rash—Medroxyprogesterone Acetate—uterine cancer	0.00039	0.00248	CcSEcCtD
Tenofovir—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.00039	0.00248	CcSEcCtD
Tenofovir—Headache—Medroxyprogesterone Acetate—uterine cancer	0.000387	0.00247	CcSEcCtD
Tenofovir—Renal impairment—Doxorubicin—uterine cancer	0.000387	0.00247	CcSEcCtD
Tenofovir—Abdominal pain—Dactinomycin—uterine cancer	0.000381	0.00243	CcSEcCtD
Tenofovir—Body temperature increased—Dactinomycin—uterine cancer	0.000381	0.00243	CcSEcCtD
Tenofovir—ABCC4—NRF2 pathway—NFE2L2—uterine cancer	0.000375	0.00389	CbGpPWpGaD
Tenofovir—Blood creatinine increased—Epirubicin—uterine cancer	0.000373	0.00238	CcSEcCtD
Tenofovir—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000367	0.00234	CcSEcCtD
Tenofovir—Chest pain—Etoposide—uterine cancer	0.000364	0.00232	CcSEcCtD
Tenofovir—Hypokalaemia—Epirubicin—uterine cancer	0.000362	0.00231	CcSEcCtD
Tenofovir—Unspecified disorder of skin and subcutaneous tissue—Etoposide—uterine cancer	0.000362	0.0023	CcSEcCtD
Tenofovir—ABCC4—NRF2 pathway—GPX3—uterine cancer	0.000358	0.00371	CbGpPWpGaD
Tenofovir—CYP1A2—Estrogen Receptor Pathway—ESR1—uterine cancer	0.000358	0.00371	CbGpPWpGaD
Tenofovir—Nasopharyngitis—Epirubicin—uterine cancer	0.000356	0.00227	CcSEcCtD
Tenofovir—Hypersensitivity—Dactinomycin—uterine cancer	0.000355	0.00226	CcSEcCtD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—ESR1—uterine cancer	0.000352	0.00365	CbGpPWpGaD
Tenofovir—Muscular weakness—Epirubicin—uterine cancer	0.000351	0.00224	CcSEcCtD
Tenofovir—Asthenia—Dactinomycin—uterine cancer	0.000346	0.00221	CcSEcCtD
Tenofovir—Blood creatinine increased—Doxorubicin—uterine cancer	0.000345	0.0022	CcSEcCtD
Tenofovir—Skin disorder—Etoposide—uterine cancer	0.000339	0.00216	CcSEcCtD
Tenofovir—Hyperhidrosis—Etoposide—uterine cancer	0.000337	0.00215	CcSEcCtD
Tenofovir—Pancreatitis—Epirubicin—uterine cancer	0.000337	0.00215	CcSEcCtD
Tenofovir—Hypokalaemia—Doxorubicin—uterine cancer	0.000335	0.00214	CcSEcCtD
Tenofovir—Anorexia—Etoposide—uterine cancer	0.000333	0.00212	CcSEcCtD
Tenofovir—AK2—Metabolism—POLD1—uterine cancer	0.000332	0.00345	CbGpPWpGaD
Tenofovir—Diarrhoea—Dactinomycin—uterine cancer	0.00033	0.0021	CcSEcCtD
Tenofovir—Nasopharyngitis—Doxorubicin—uterine cancer	0.000329	0.0021	CcSEcCtD
Tenofovir—Muscular weakness—Doxorubicin—uterine cancer	0.000325	0.00207	CcSEcCtD
Tenofovir—Upper respiratory tract infection—Epirubicin—uterine cancer	0.00032	0.00204	CcSEcCtD
Tenofovir—ABCC2—NRF2 pathway—NFE2L2—uterine cancer	0.000316	0.00328	CbGpPWpGaD
Tenofovir—Pancreatitis—Doxorubicin—uterine cancer	0.000312	0.00199	CcSEcCtD
Tenofovir—Weight decreased—Epirubicin—uterine cancer	0.000311	0.00198	CcSEcCtD
Tenofovir—Dyspnoea—Etoposide—uterine cancer	0.000311	0.00198	CcSEcCtD
Tenofovir—AK2—Metabolism—AKR1C1—uterine cancer	0.000311	0.00322	CbGpPWpGaD
Tenofovir—Hyperglycaemia—Epirubicin—uterine cancer	0.00031	0.00198	CcSEcCtD
Tenofovir—Pneumonia—Epirubicin—uterine cancer	0.000309	0.00197	CcSEcCtD
Tenofovir—NME1—Metabolism—SRD5A2—uterine cancer	0.000308	0.00319	CbGpPWpGaD
Tenofovir—NME1—Metabolism—NDUFB11—uterine cancer	0.000308	0.00319	CbGpPWpGaD
Tenofovir—Infestation—Epirubicin—uterine cancer	0.000307	0.00196	CcSEcCtD
Tenofovir—Infestation NOS—Epirubicin—uterine cancer	0.000307	0.00196	CcSEcCtD
Tenofovir—Vomiting—Dactinomycin—uterine cancer	0.000307	0.00195	CcSEcCtD
Tenofovir—NME1—Validated targets of C-MYC transcriptional activation—TP53—uterine cancer	0.000305	0.00316	CbGpPWpGaD
Tenofovir—Rash—Dactinomycin—uterine cancer	0.000304	0.00194	CcSEcCtD
Tenofovir—Decreased appetite—Etoposide—uterine cancer	0.000303	0.00193	CcSEcCtD
Tenofovir—ABCC2—NRF2 pathway—GPX3—uterine cancer	0.000302	0.00313	CbGpPWpGaD
Tenofovir—Renal failure—Epirubicin—uterine cancer	0.000302	0.00192	CcSEcCtD
Tenofovir—Gastrointestinal disorder—Etoposide—uterine cancer	0.000301	0.00192	CcSEcCtD
Tenofovir—Fatigue—Etoposide—uterine cancer	0.000301	0.00192	CcSEcCtD
Tenofovir—Neuropathy peripheral—Epirubicin—uterine cancer	0.000301	0.00192	CcSEcCtD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor Pathway—NFE2L2—uterine cancer	0.000299	0.0031	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor—NFE2L2—uterine cancer	0.000299	0.0031	CbGpPWpGaD
Tenofovir—Pain—Etoposide—uterine cancer	0.000299	0.0019	CcSEcCtD
Tenofovir—Upper respiratory tract infection—Doxorubicin—uterine cancer	0.000296	0.00189	CcSEcCtD
Tenofovir—Sweating—Epirubicin—uterine cancer	0.000294	0.00187	CcSEcCtD
Tenofovir—NME2—Metabolism—STAR—uterine cancer	0.000294	0.00304	CbGpPWpGaD
Tenofovir—NME2—Metabolism—AKR1B1—uterine cancer	0.000294	0.00304	CbGpPWpGaD
Tenofovir—Haematuria—Epirubicin—uterine cancer	0.000293	0.00186	CcSEcCtD
Tenofovir—Hepatobiliary disease—Epirubicin—uterine cancer	0.00029	0.00185	CcSEcCtD
Tenofovir—Weight decreased—Doxorubicin—uterine cancer	0.000288	0.00184	CcSEcCtD
Tenofovir—Sinusitis—Epirubicin—uterine cancer	0.000288	0.00183	CcSEcCtD
Tenofovir—Hyperglycaemia—Doxorubicin—uterine cancer	0.000287	0.00183	CcSEcCtD
Tenofovir—Nausea—Dactinomycin—uterine cancer	0.000286	0.00183	CcSEcCtD
Tenofovir—Pneumonia—Doxorubicin—uterine cancer	0.000286	0.00182	CcSEcCtD
Tenofovir—Gastrointestinal pain—Etoposide—uterine cancer	0.000285	0.00182	CcSEcCtD
Tenofovir—Infestation NOS—Doxorubicin—uterine cancer	0.000284	0.00181	CcSEcCtD
Tenofovir—Infestation—Doxorubicin—uterine cancer	0.000284	0.00181	CcSEcCtD
Tenofovir—Renal failure—Doxorubicin—uterine cancer	0.000279	0.00178	CcSEcCtD
Tenofovir—Neuropathy peripheral—Doxorubicin—uterine cancer	0.000278	0.00177	CcSEcCtD
Tenofovir—AK2—Metabolism—RRM2—uterine cancer	0.000277	0.00287	CbGpPWpGaD
Tenofovir—Body temperature increased—Etoposide—uterine cancer	0.000276	0.00176	CcSEcCtD
Tenofovir—Abdominal pain—Etoposide—uterine cancer	0.000276	0.00176	CcSEcCtD
Tenofovir—Hepatitis—Epirubicin—uterine cancer	0.000275	0.00176	CcSEcCtD
Tenofovir—Sweating—Doxorubicin—uterine cancer	0.000272	0.00173	CcSEcCtD
Tenofovir—Urinary tract disorder—Epirubicin—uterine cancer	0.000272	0.00173	CcSEcCtD
Tenofovir—Haematuria—Doxorubicin—uterine cancer	0.000271	0.00173	CcSEcCtD
Tenofovir—Connective tissue disorder—Epirubicin—uterine cancer	0.000271	0.00172	CcSEcCtD
Tenofovir—Urethral disorder—Epirubicin—uterine cancer	0.00027	0.00172	CcSEcCtD
Tenofovir—AK2—Metabolism—DCN—uterine cancer	0.000269	0.00279	CbGpPWpGaD
Tenofovir—Hepatobiliary disease—Doxorubicin—uterine cancer	0.000268	0.00171	CcSEcCtD
Tenofovir—Sinusitis—Doxorubicin—uterine cancer	0.000266	0.0017	CcSEcCtD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—ERBB2—uterine cancer	0.000258	0.00268	CbGpPWpGaD
Tenofovir—Hypersensitivity—Etoposide—uterine cancer	0.000257	0.00164	CcSEcCtD
Tenofovir—Hepatitis—Doxorubicin—uterine cancer	0.000255	0.00162	CcSEcCtD
Tenofovir—AK2—Metabolism—CYP11A1—uterine cancer	0.000253	0.00263	CbGpPWpGaD
Tenofovir—Urinary tract disorder—Doxorubicin—uterine cancer	0.000252	0.0016	CcSEcCtD
Tenofovir—Asthenia—Etoposide—uterine cancer	0.00025	0.0016	CcSEcCtD
Tenofovir—Connective tissue disorder—Doxorubicin—uterine cancer	0.00025	0.0016	CcSEcCtD
Tenofovir—Urethral disorder—Doxorubicin—uterine cancer	0.00025	0.00159	CcSEcCtD
Tenofovir—Immune system disorder—Epirubicin—uterine cancer	0.000249	0.00159	CcSEcCtD
Tenofovir—Mediastinal disorder—Epirubicin—uterine cancer	0.000248	0.00158	CcSEcCtD
Tenofovir—Pruritus—Etoposide—uterine cancer	0.000247	0.00157	CcSEcCtD
Tenofovir—Mental disorder—Epirubicin—uterine cancer	0.000241	0.00154	CcSEcCtD
Tenofovir—Malnutrition—Epirubicin—uterine cancer	0.00024	0.00153	CcSEcCtD
Tenofovir—AK2—Metabolism—AKR1C3—uterine cancer	0.000239	0.00248	CbGpPWpGaD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—CDKN1B—uterine cancer	0.000239	0.00248	CbGpPWpGaD
Tenofovir—Diarrhoea—Etoposide—uterine cancer	0.000239	0.00152	CcSEcCtD
Tenofovir—Flatulence—Epirubicin—uterine cancer	0.000236	0.00151	CcSEcCtD
Tenofovir—CYP1A2—Arachidonic acid metabolism—AKR1C3—uterine cancer	0.000234	0.00243	CbGpPWpGaD
Tenofovir—Back pain—Epirubicin—uterine cancer	0.000232	0.00148	CcSEcCtD
Tenofovir—Dizziness—Etoposide—uterine cancer	0.000231	0.00147	CcSEcCtD
Tenofovir—NME2—Metabolism—POLD1—uterine cancer	0.00023	0.00239	CbGpPWpGaD
Tenofovir—Immune system disorder—Doxorubicin—uterine cancer	0.00023	0.00147	CcSEcCtD
Tenofovir—Mediastinal disorder—Doxorubicin—uterine cancer	0.00023	0.00146	CcSEcCtD
Tenofovir—ABCC4—Fluoropyrimidine Activity—TP53—uterine cancer	0.000229	0.00238	CbGpPWpGaD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—CTNNB1—uterine cancer	0.000226	0.00234	CbGpPWpGaD
Tenofovir—Mental disorder—Doxorubicin—uterine cancer	0.000223	0.00142	CcSEcCtD
Tenofovir—NME1—Metabolism—AKR1B1—uterine cancer	0.000223	0.00231	CbGpPWpGaD
Tenofovir—NME1—Metabolism—STAR—uterine cancer	0.000223	0.00231	CbGpPWpGaD
Tenofovir—Vomiting—Etoposide—uterine cancer	0.000222	0.00141	CcSEcCtD
Tenofovir—Malnutrition—Doxorubicin—uterine cancer	0.000222	0.00141	CcSEcCtD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—PTEN—uterine cancer	0.00022	0.00228	CbGpPWpGaD
Tenofovir—Rash—Etoposide—uterine cancer	0.00022	0.0014	CcSEcCtD
Tenofovir—Dermatitis—Etoposide—uterine cancer	0.00022	0.0014	CcSEcCtD
Tenofovir—Headache—Etoposide—uterine cancer	0.000219	0.00139	CcSEcCtD
Tenofovir—Flatulence—Doxorubicin—uterine cancer	0.000219	0.00139	CcSEcCtD
Tenofovir—NME2—Metabolism—AKR1C1—uterine cancer	0.000216	0.00223	CbGpPWpGaD
Tenofovir—Back pain—Doxorubicin—uterine cancer	0.000215	0.00137	CcSEcCtD
Tenofovir—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP11A1—uterine cancer	0.000214	0.00222	CbGpPWpGaD
Tenofovir—CYP1A2—Oxidation by Cytochrome P450—CYP11A1—uterine cancer	0.000211	0.00219	CbGpPWpGaD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—EP300—uterine cancer	0.00021	0.00218	CbGpPWpGaD
Tenofovir—Nausea—Etoposide—uterine cancer	0.000207	0.00132	CcSEcCtD
Tenofovir—Chest pain—Epirubicin—uterine cancer	0.000204	0.0013	CcSEcCtD
Tenofovir—Arthralgia—Epirubicin—uterine cancer	0.000204	0.0013	CcSEcCtD
Tenofovir—Myalgia—Epirubicin—uterine cancer	0.000204	0.0013	CcSEcCtD
Tenofovir—Anxiety—Epirubicin—uterine cancer	0.000203	0.0013	CcSEcCtD
Tenofovir—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	0.000203	0.00129	CcSEcCtD
Tenofovir—ABCC4—Ectoderm Differentiation—FGFR2—uterine cancer	0.0002	0.00207	CbGpPWpGaD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—VEGFA—uterine cancer	0.000199	0.00206	CbGpPWpGaD
Tenofovir—CYP1A2—Tryptophan metabolism—CYP19A1—uterine cancer	0.000195	0.00202	CbGpPWpGaD
Tenofovir—NME2—Metabolism—RRM2—uterine cancer	0.000192	0.00199	CbGpPWpGaD
Tenofovir—Nervous system disorder—Epirubicin—uterine cancer	0.000192	0.00122	CcSEcCtD
Tenofovir—Skin disorder—Epirubicin—uterine cancer	0.00019	0.00121	CcSEcCtD
Tenofovir—Hyperhidrosis—Epirubicin—uterine cancer	0.000189	0.00121	CcSEcCtD
Tenofovir—Arthralgia—Doxorubicin—uterine cancer	0.000189	0.0012	CcSEcCtD
Tenofovir—Myalgia—Doxorubicin—uterine cancer	0.000189	0.0012	CcSEcCtD
Tenofovir—Chest pain—Doxorubicin—uterine cancer	0.000189	0.0012	CcSEcCtD
Tenofovir—Anxiety—Doxorubicin—uterine cancer	0.000188	0.0012	CcSEcCtD
Tenofovir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	0.000188	0.0012	CcSEcCtD
Tenofovir—Anorexia—Epirubicin—uterine cancer	0.000187	0.00119	CcSEcCtD
Tenofovir—AK2—Metabolism—STK11—uterine cancer	0.000186	0.00193	CbGpPWpGaD
Tenofovir—AK2—Metabolism—CYP19A1—uterine cancer	0.000186	0.00193	CbGpPWpGaD
Tenofovir—NME2—Metabolism—DCN—uterine cancer	0.000186	0.00193	CbGpPWpGaD
Tenofovir—SLC22A8—Transmembrane transport of small molecules—ABCC9—uterine cancer	0.000185	0.00192	CbGpPWpGaD
Tenofovir—Musculoskeletal discomfort—Epirubicin—uterine cancer	0.000178	0.00114	CcSEcCtD
Tenofovir—ABCC4—Transmembrane transport of small molecules—ABCC9—uterine cancer	0.000178	0.00184	CbGpPWpGaD
Tenofovir—Nervous system disorder—Doxorubicin—uterine cancer	0.000178	0.00113	CcSEcCtD
Tenofovir—Insomnia—Epirubicin—uterine cancer	0.000177	0.00113	CcSEcCtD
Tenofovir—Skin disorder—Doxorubicin—uterine cancer	0.000176	0.00112	CcSEcCtD
Tenofovir—NME2—Metabolism—CYP11A1—uterine cancer	0.000176	0.00182	CbGpPWpGaD
Tenofovir—Hyperhidrosis—Doxorubicin—uterine cancer	0.000175	0.00112	CcSEcCtD
Tenofovir—NME1—Metabolism—POLD1—uterine cancer	0.000175	0.00181	CbGpPWpGaD
Tenofovir—Dyspnoea—Epirubicin—uterine cancer	0.000174	0.00111	CcSEcCtD
Tenofovir—CYP1A2—Phase 1 - Functionalization of compounds—CYP11A1—uterine cancer	0.000174	0.0018	CbGpPWpGaD
Tenofovir—Anorexia—Doxorubicin—uterine cancer	0.000173	0.0011	CcSEcCtD
Tenofovir—Dyspepsia—Epirubicin—uterine cancer	0.000172	0.0011	CcSEcCtD
Tenofovir—Decreased appetite—Epirubicin—uterine cancer	0.00017	0.00108	CcSEcCtD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—KRAS—uterine cancer	0.000169	0.00175	CbGpPWpGaD
Tenofovir—Gastrointestinal disorder—Epirubicin—uterine cancer	0.000169	0.00108	CcSEcCtD
Tenofovir—Fatigue—Epirubicin—uterine cancer	0.000169	0.00108	CcSEcCtD
Tenofovir—Pain—Epirubicin—uterine cancer	0.000167	0.00107	CcSEcCtD
Tenofovir—NME2—Metabolism—AKR1C3—uterine cancer	0.000166	0.00172	CbGpPWpGaD
Tenofovir—Musculoskeletal discomfort—Doxorubicin—uterine cancer	0.000165	0.00105	CcSEcCtD
Tenofovir—Insomnia—Doxorubicin—uterine cancer	0.000164	0.00104	CcSEcCtD
Tenofovir—CYP1A2—Metapathway biotransformation—AKR1B10—uterine cancer	0.000164	0.0017	CbGpPWpGaD
Tenofovir—NME1—Metabolism—AKR1C1—uterine cancer	0.000163	0.00169	CbGpPWpGaD
Tenofovir—Dyspnoea—Doxorubicin—uterine cancer	0.000161	0.00103	CcSEcCtD
Tenofovir—Gastrointestinal pain—Epirubicin—uterine cancer	0.00016	0.00102	CcSEcCtD
Tenofovir—Dyspepsia—Doxorubicin—uterine cancer	0.000159	0.00102	CcSEcCtD
Tenofovir—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP19A1—uterine cancer	0.000158	0.00163	CbGpPWpGaD
Tenofovir—Decreased appetite—Doxorubicin—uterine cancer	0.000157	0.001	CcSEcCtD
Tenofovir—Gastrointestinal disorder—Doxorubicin—uterine cancer	0.000156	0.000996	CcSEcCtD
Tenofovir—Fatigue—Doxorubicin—uterine cancer	0.000156	0.000995	CcSEcCtD
Tenofovir—CYP1A2—Oxidation by Cytochrome P450—CYP19A1—uterine cancer	0.000156	0.00161	CbGpPWpGaD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—PIK3CA—uterine cancer	0.000155	0.00161	CbGpPWpGaD
Tenofovir—Pain—Doxorubicin—uterine cancer	0.000155	0.000987	CcSEcCtD
Tenofovir—SLC22A6—Transmembrane transport of small molecules—ABCC9—uterine cancer	0.000155	0.00161	CbGpPWpGaD
Tenofovir—Abdominal pain—Epirubicin—uterine cancer	0.000155	0.000986	CcSEcCtD
Tenofovir—Body temperature increased—Epirubicin—uterine cancer	0.000155	0.000986	CcSEcCtD
Tenofovir—CYP1A2—Metapathway biotransformation—AKR1B1—uterine cancer	0.000152	0.00158	CbGpPWpGaD
Tenofovir—ABCC4—Ectoderm Differentiation—CCL2—uterine cancer	0.00015	0.00156	CbGpPWpGaD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—TP53—uterine cancer	0.00015	0.00156	CbGpPWpGaD
Tenofovir—ABCC2—Transmembrane transport of small molecules—ABCC9—uterine cancer	0.00015	0.00155	CbGpPWpGaD
Tenofovir—ABCC4—Platelet degranulation—VEGFA—uterine cancer	0.000149	0.00155	CbGpPWpGaD
Tenofovir—Gastrointestinal pain—Doxorubicin—uterine cancer	0.000148	0.000944	CcSEcCtD
Tenofovir—NME1—Metabolism—RRM2—uterine cancer	0.000146	0.00151	CbGpPWpGaD
Tenofovir—Hypersensitivity—Epirubicin—uterine cancer	0.000144	0.000919	CcSEcCtD
Tenofovir—Abdominal pain—Doxorubicin—uterine cancer	0.000143	0.000912	CcSEcCtD
Tenofovir—Body temperature increased—Doxorubicin—uterine cancer	0.000143	0.000912	CcSEcCtD
Tenofovir—ABCC4—Response to elevated platelet cytosolic Ca2+—VEGFA—uterine cancer	0.000142	0.00148	CbGpPWpGaD
Tenofovir—NME1—Metabolism—DCN—uterine cancer	0.000141	0.00147	CbGpPWpGaD
Tenofovir—Asthenia—Epirubicin—uterine cancer	0.00014	0.000895	CcSEcCtD
Tenofovir—AK2—Metabolism—MTHFR—uterine cancer	0.00014	0.00145	CbGpPWpGaD
Tenofovir—Pruritus—Epirubicin—uterine cancer	0.000138	0.000882	CcSEcCtD
Tenofovir—Diarrhoea—Epirubicin—uterine cancer	0.000134	0.000853	CcSEcCtD
Tenofovir—Hypersensitivity—Doxorubicin—uterine cancer	0.000133	0.00085	CcSEcCtD
Tenofovir—NME1—Metabolism—CYP11A1—uterine cancer	0.000133	0.00138	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor—ESR1—uterine cancer	0.00013	0.00135	CbGpPWpGaD
Tenofovir—Asthenia—Doxorubicin—uterine cancer	0.00013	0.000828	CcSEcCtD
Tenofovir—Dizziness—Epirubicin—uterine cancer	0.000129	0.000825	CcSEcCtD
Tenofovir—NME2—Metabolism—CYP19A1—uterine cancer	0.000129	0.00134	CbGpPWpGaD
Tenofovir—NME2—Metabolism—STK11—uterine cancer	0.000129	0.00134	CbGpPWpGaD
Tenofovir—Pruritus—Doxorubicin—uterine cancer	0.000128	0.000816	CcSEcCtD
Tenofovir—CYP1A2—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	0.000128	0.00132	CbGpPWpGaD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—AKT1—uterine cancer	0.000127	0.00132	CbGpPWpGaD
Tenofovir—NME1—Metabolism—AKR1C3—uterine cancer	0.000126	0.0013	CbGpPWpGaD
Tenofovir—Vomiting—Epirubicin—uterine cancer	0.000124	0.000793	CcSEcCtD
Tenofovir—Diarrhoea—Doxorubicin—uterine cancer	0.000124	0.00079	CcSEcCtD
Tenofovir—Rash—Epirubicin—uterine cancer	0.000123	0.000786	CcSEcCtD
Tenofovir—Dermatitis—Epirubicin—uterine cancer	0.000123	0.000786	CcSEcCtD
Tenofovir—Headache—Epirubicin—uterine cancer	0.000123	0.000781	CcSEcCtD
Tenofovir—Dizziness—Doxorubicin—uterine cancer	0.00012	0.000763	CcSEcCtD
Tenofovir—Nausea—Epirubicin—uterine cancer	0.000116	0.000741	CcSEcCtD
Tenofovir—ABCC4—Hemostasis—IRF1—uterine cancer	0.000115	0.0012	CbGpPWpGaD
Tenofovir—Vomiting—Doxorubicin—uterine cancer	0.000115	0.000734	CcSEcCtD
Tenofovir—Rash—Doxorubicin—uterine cancer	0.000114	0.000728	CcSEcCtD
Tenofovir—Dermatitis—Doxorubicin—uterine cancer	0.000114	0.000727	CcSEcCtD
Tenofovir—Headache—Doxorubicin—uterine cancer	0.000113	0.000723	CcSEcCtD
Tenofovir—CYP1A2—Metapathway biotransformation—AKR1C1—uterine cancer	0.000112	0.00116	CbGpPWpGaD
Tenofovir—ABCC4—Ectoderm Differentiation—CTNNB1—uterine cancer	0.00011	0.00114	CbGpPWpGaD
Tenofovir—Nausea—Doxorubicin—uterine cancer	0.000108	0.000685	CcSEcCtD
Tenofovir—CYP1A2—Metapathway biotransformation—GPX3—uterine cancer	9.8e-05	0.00102	CbGpPWpGaD
Tenofovir—NME1—Metabolism—STK11—uterine cancer	9.8e-05	0.00102	CbGpPWpGaD
Tenofovir—NME1—Metabolism—CYP19A1—uterine cancer	9.8e-05	0.00102	CbGpPWpGaD
Tenofovir—NME2—Metabolism—MTHFR—uterine cancer	9.71e-05	0.00101	CbGpPWpGaD
Tenofovir—CYP1A2—Biological oxidations—CYP11A1—uterine cancer	9.22e-05	0.000956	CbGpPWpGaD
Tenofovir—CYP1A2—Metapathway biotransformation—CYP11A1—uterine cancer	9.1e-05	0.000943	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—uterine cancer	8.85e-05	0.000918	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—uterine cancer	8.85e-05	0.000918	CbGpPWpGaD
Tenofovir—CYP1A2—Metapathway biotransformation—AKR1C3—uterine cancer	8.59e-05	0.000891	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	8.19e-05	0.000849	CbGpPWpGaD
Tenofovir—AK2—Metabolism—PTEN—uterine cancer	7.8e-05	0.000808	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor—EP300—uterine cancer	7.77e-05	0.000806	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—uterine cancer	7.77e-05	0.000806	CbGpPWpGaD
Tenofovir—AK2—Metabolism—EP300—uterine cancer	7.43e-05	0.000771	CbGpPWpGaD
Tenofovir—NME1—Metabolism—MTHFR—uterine cancer	7.36e-05	0.000763	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—uterine cancer	7.36e-05	0.000763	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—uterine cancer	7.27e-05	0.000754	CbGpPWpGaD
Tenofovir—CYP1A2—Biological oxidations—CYP19A1—uterine cancer	6.79e-05	0.000704	CbGpPWpGaD
Tenofovir—CYP1A2—Metapathway biotransformation—CYP19A1—uterine cancer	6.69e-05	0.000694	CbGpPWpGaD
Tenofovir—ABCC4—Platelet activation, signaling and aggregation—VEGFA—uterine cancer	6.62e-05	0.000687	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—uterine cancer	6.26e-05	0.000649	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—STAR—uterine cancer	5.92e-05	0.000614	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	5.92e-05	0.000614	CbGpPWpGaD
Tenofovir—AK2—Metabolism—PIK3CA—uterine cancer	5.5e-05	0.00057	CbGpPWpGaD
Tenofovir—NME2—Metabolism—PTEN—uterine cancer	5.4e-05	0.00056	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—uterine cancer	5.32e-05	0.000551	CbGpPWpGaD
Tenofovir—ABCC4—Platelet activation, signaling and aggregation—PIK3CA—uterine cancer	5.17e-05	0.000536	CbGpPWpGaD
Tenofovir—NME2—Metabolism—EP300—uterine cancer	5.15e-05	0.000534	CbGpPWpGaD
Tenofovir—AK2—Metabolism—AKT1—uterine cancer	4.49e-05	0.000466	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	4.34e-05	0.00045	CbGpPWpGaD
Tenofovir—ABCC4—Platelet activation, signaling and aggregation—AKT1—uterine cancer	4.23e-05	0.000438	CbGpPWpGaD
Tenofovir—NME1—Metabolism—PTEN—uterine cancer	4.09e-05	0.000425	CbGpPWpGaD
Tenofovir—NME1—Metabolism—EP300—uterine cancer	3.91e-05	0.000405	CbGpPWpGaD
Tenofovir—NME2—Metabolism—PIK3CA—uterine cancer	3.81e-05	0.000395	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—SRD5A2—uterine cancer	3.65e-05	0.000378	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—NDUFB11—uterine cancer	3.65e-05	0.000378	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—EP300—uterine cancer	3.61e-05	0.000374	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	3.54e-05	0.000367	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—VEGFA—uterine cancer	3.41e-05	0.000354	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—NRAS—uterine cancer	3.37e-05	0.00035	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	3.34e-05	0.000347	CbGpPWpGaD
Tenofovir—NME2—Metabolism—AKT1—uterine cancer	3.11e-05	0.000323	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—KRAS—uterine cancer	2.9e-05	0.000301	CbGpPWpGaD
Tenofovir—NME1—Metabolism—PIK3CA—uterine cancer	2.89e-05	0.0003	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—PIK3CA—uterine cancer	2.67e-05	0.000277	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—AKR1B1—uterine cancer	2.64e-05	0.000273	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—STAR—uterine cancer	2.64e-05	0.000273	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	2.61e-05	0.00027	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—TP53—uterine cancer	2.58e-05	0.000268	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—HRAS—uterine cancer	2.47e-05	0.000256	CbGpPWpGaD
Tenofovir—NME1—Metabolism—AKT1—uterine cancer	2.36e-05	0.000245	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—AKT1—uterine cancer	2.18e-05	0.000226	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—POLD1—uterine cancer	2.07e-05	0.000214	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—AKR1C1—uterine cancer	1.93e-05	0.000201	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—RRM2—uterine cancer	1.72e-05	0.000179	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—DCN—uterine cancer	1.67e-05	0.000174	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—CYP11A1—uterine cancer	1.58e-05	0.000164	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—AKR1C3—uterine cancer	1.49e-05	0.000154	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—STK11—uterine cancer	1.16e-05	0.00012	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—CYP19A1—uterine cancer	1.16e-05	0.00012	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	1.09e-05	0.000113	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—EP300—uterine cancer	1.04e-05	0.000108	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—MTHFR—uterine cancer	8.72e-06	9.04e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	7.68e-06	7.97e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—PTEN—uterine cancer	4.85e-06	5.03e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—EP300—uterine cancer	4.63e-06	4.8e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—PIK3CA—uterine cancer	3.42e-06	3.55e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—AKT1—uterine cancer	2.8e-06	2.9e-05	CbGpPWpGaD
